Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
EUDA Health Holdings Limited (EUDA)
USD11.65
+0.47 (+4.20%)
SG NASDAQ Healthcare Medical - Healthcare Information Services
Address
1 Pemimpin Drive 576151
Singapore, SG
Singapore, SG
CEO
Alfred Lim
Website
euda.com
IPO
2021-12-14
CIK 1847846 ISIN VGG3142E1473
Also trades on
NASDAQ Capital Market · EUDA (USD)
NASDAQ Capital Market · EUDAW (USD)
NASDAQ Global Market · LAX (USD)
NASDAQ Global Market · LAXXR (USD)
NASDAQ Global Market · LAXXU (USD)
NASDAQ Global Market · LAXXW (USD)
Description
EUDA Health Limited, established in 2019, is a Singapore-based enterprise dedicated to advancing digital healthcare. It provides an innovative platform facilitating online medical consultations for routine, non-urgent health concerns. This entity functions as a subsidiary of Watermark Developments Limited.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD11.65
+0.47 (+4.20%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
116.5K
Beta
0.64
Float Shares
941.2K
Free Float %
50.4%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +4.65% | +10.51% | +114.29% | -0.41% | -75.59% | -68.83% | -82.31% | -46.27% | -92.54% | -92.54% | -92.54% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (1 ratings, all time)
Buy
Price Targets & DCF
Current price
11.65
Ratings Trend (MoM)
100% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 1 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
-44.85
Distress
Piotroski F-Score
3 / 9
Average
MOAT Score
1 / 10
No MOAT
Composite Rating
D+
Overall Score
1 / 5
Low
DCF Score
1 / 5
Low
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Healthcare Information Services: +14.2%+70.0% ★ Q4'25: +78.9% (vs Q4'24)
-
EPS growth Medical - Healthcare Information Services: +43.1%+84.2% ★ Q4'25: -75.0% (vs Q4'24)
-
FCF margin FCF growth · Medical - Healthcare Information Services: +49.2%-39.5% Q4'25: -33.6% (vs Q4'24)
-
EBIT margin Medical - Healthcare Information Services: +8.8%-36.6% Q4'25: -34.8% (vs Q4'24)
-
ROIC Medical - Healthcare Information Services: +5.2%— Q4'25: +118.3% (vs Q4'24)
-
Share dilution Medical - Healthcare Information Services: -0.1%+14.5% Q4'25: +2.7% (vs Q4'24)
-
Debt / EBITDA Net debt/EBITDA · Medical - Healthcare Information Services: -0.74×-1.15× Q4'25: -1.00× (vs Q4'24)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|
| Revenue |
3.71M
est: 11.80M (-68.6%)
|
4.01M
est: 5.07M (-21.0%)
|
6.82M
est: 9.33M (-26.9%)
|
27.23M
27.23M – 27.23M
+191.9% YoY
|
| EBITDA |
-8.30M
est: -6.57M (-26.4%)
|
-17.42M
est: -3.06M (-469.9%)
|
-2.09M
est: -5.62M (+62.8%)
|
-16.41M
-16.41M – -16.41M
-191.9% YoY
|
| EBIT |
-8.41M
est: -6.76M (-24.4%)
|
-17.60M
est: -3.18M (-453.9%)
|
-2.50M
est: -5.84M (+57.2%)
|
-17.05M
-17.05M – -17.05M
-191.9% YoY
|
| Net Income |
-10.04M
|
-15.36M
est: -1.08M (-1,325.2%)
|
-2.77M
est: 743.1K (-473.1%)
|
2.97M
2.97M – 2.97M
+300.0% YoY
|
| SGA |
4.80M
est: 11.43M (-58.0%)
|
3.34M
est: 5.19M (-35.6%)
|
5.43M
est: 9.55M (-43.1%)
|
27.86M
27.86M – 27.86M
+191.9% YoY
|
| EPS |
-7.40
|
-9.40
est: -0.58 (-1,520.7%)
|
-1.49
est: 0.40 (-472.5%)
|
1.60
1.60 – 1.60
+300.0% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-11 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-08 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-07 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-05 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-01 | C | 2/5 | 1/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | C | 2/5 | 1/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | C | 2/5 | 1/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | C | 2/5 | 1/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | C | 2/5 | 1/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | C | 2/5 | 1/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | C | 2/5 | 1/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | C | 2/5 | 1/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | C | 2/5 | 1/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | C | 2/5 | 1/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | C | 2/5 | 1/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | C | 2/5 | 1/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-2.06M
OE per share TTM
-1.12
Owner's Yield
-7.71%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
4.0%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
1
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | MENG DONG | 6.50M | 26.40% | 6.50M | — | 6.50M | — | IN | SINGAPOREAN | 2024-03-27 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
This company is not held by any ETF in our universe.
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Buys
0
Sells
0
Shares acquired
—
Shares disposed
—
Cash buys
—
Cash sales
—
Net activity
+0
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-18 | Tay Whye Shin | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2026-03-18 | Liew Kwong Yeow | Director | — | — | Ordinary Shares | 0 | 0.00 | — | 3,000 | D | ↗ |
| 2026-03-18 | Lew Chern Yong | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2026-03-18 | Huang Bo | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2023-06-12 | Chen Wei Wen Kelvin | Director / Officer | J-Other | D | Ordinary Share | 271,867 | 0.00 | — | 578,439 | — | ↗ |
| 2023-05-22 | Wong KongYew | Director | — | D | Common Stock | 0 | 0.00 | — | 0 | — | ↗ |
| 2023-05-22 | Rajpal Ajay | Director | — | D | Ordinary Shares | 0 | 0.00 | — | 3,000 | — | ↗ |
| 2023-05-16 | Chen Wei Wen Kelvin | Director / Officer | J-Other | A | Ordinary Share | 850,306 | 850,306.00 | 723.02B | 850,306 | — | ↗ |
| 2022-11-17 | YAP GUAN HONG WILLIAM | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2022-11-17 | Tan Meng Dong (James) | Director | J-Other | A | Ordinary Shares | 2,776,000 | 0.00 | — | 2,776,000 | — | ↗ |
| 2022-11-17 | Tan Daniel | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2022-11-17 | Sobak Steven John | Officer | — | I | Ordinary Share | 0 | 0.00 | — | 5,742 | — | ↗ |
| 2022-11-17 | Rajpal Ajay | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2022-11-17 | Lim Thien Su Gerald | — | — | — | — | — | — | — | 0 | — | ↗ |
| 2022-11-17 | Lim Alfred | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2022-11-17 | Liew Kwong Yeow | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2022-11-17 | Chen Wei Wen Kelvin | Officer | — | I | Ordinary Share | 0 | 0.00 | — | 1,073,333 | — | ↗ |
| 2022-11-17 | Chan Kim Hing | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2022-11-17 | Capes David Francis | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2022-11-17 | Arrow Alexander K. | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-11-24 | Tan Meng Dong (James) | Director | J-Other | A | Ordinary Shares | 3,000 | 0.00 | — | 3,000 | — | ↗ |
| 2021-11-22 | YAP GUAN HONG WILLIAM | Director / Officer | — | D | Ordinary Shares, no par value | 0 | 0.00 | — | 3,000 | — | ↗ |
| 2021-11-22 | Tan Meng Dong (James) | Director / Officer / 10% Owner | — | D | Ordinary shares, no par value | 0 | 0.00 | — | 3,000 | — | ↗ |
| 2021-11-22 | Rajpal Ajay | Director | — | D | Ordinary Shares, no par value | 0 | 0.00 | — | 3,000 | — | ↗ |
| 2021-11-22 | Liew Kwong Yeow | Director | — | D | Ordinary Shares, no par value | 0 | 0.00 | — | 3,000 | — | ↗ |
| 2021-11-22 | Arrow Alexander K. | Director | — | D | Ordinary Shares, no par value | 0 | 0.00 | — | 3,000 | — | ↗ |
| 2021-11-22 | 8i Holdings 2 Pte Ltd | 10% Owner | — | D | Ordinary Shares, no par value | 0 | 0.00 | — | 2,141,250 | — | ↗ |
Executive team
Top executives
EBIT / Employee
-21.3K
Shares Outstanding
1.87M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Daniel Tan | Chief Technology Officer | 137.0K | male |
| Aaron Lim | Operational Director | — | male |
| Alex Lai | Chief Executive Officer of CK Health Plus | — | male |
| Alfred Lim | Chief Executive Officer & Executive Director | — | male |
| Whye Shin Tay | Interim Chief Financial Officer | — | female |
ESG Rating
ESG Score History MEDICAL - HEALTHCARE INFORMATION SERVICES
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for EUDA
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
